Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, ...

Some might say it looks like a finger. Others might see a worm. Scientists in the field often liken it to an antenna. The technical name is primary cilium. This slender, microscopic appendage juts out ...

The Government has announced it is cracking down on the number of students in the UK who go on to claim asylum once their visas come to an end. Here the PA news agency looks at the key numbers and ...

Positive results from the global COAST 1 phase 3 study (clinical study identifier: NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody that targets OX40-ligand ...

Some 13% of people claiming asylum in the year to June 2025 originally arrived in the UK on a study visa (David Angel/Alamy) The Government has announced it is cracking down on the number of students ...

The US Department of Homeland Security (DHS) announced on Wednesday that it has put forward new immigration rules that would end the current “duration of status” system and introduce fixed admission ...

Merck, known as MSD outside of the United States and Canada, announced positive topline results from the phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate, an ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The number of asylum claims by people who entered the UK on a study visa has fallen in recent months. The Government has announced it is cracking down on the number of students in the UK who go on to ...

Despite years of engagement in a global chip war, China remains a vital operation base for several Asian-grown champions. But even from afar, Washington still holds key levers of power. The latest ...